論文掲載情報（英文）

Imamura M

Long-term follow-up of efficacy and safety in elderly patients with chronic myeloid leukemia treated with intermittent low dose dasatinib therapy. Leukemia Research Reports.doi: 10.1016/j.lrr.2024.100452.　

Aiba M

Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma. J Infect Chemother.30(10):1065-1068,2024

Sugita J

Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor. Bone Marrow Transplant.59(3):344-349,2024

Sugita J

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation. Hematology. 2024 Dec;29(1):2332866. doi: 10.1080/16078454.2024.2332866.

Sugita J

Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia. Ann Hematol. 2024 Aug 17. doi: 10.1007/s00277-024-05944-0.

Ogasawara M

Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis. Intern Med. 63(2):197-205,2024

Yanagi M

Nelarabine-containing salvage therapy and conditioning regimen in transplants for pediatric T-cell acute lymphoblastic leukemia and lymphoma. International Journal of Hematology 119(3):327-333,2024

Sano H

Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study. International Journal of Hematology 119(6):745-754,2024

Sano H

Analysis of non-alcoholic fatty liver disease during induction therapy for B-cell precursor acute lymphoblastic leukemia in children and adolescents. Pediatrics and Neonatology 65(1):23-30,2024

Ogasawara M

Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis. Intern Med. 2023 May 24. doi: 10.2169/internalmedicine.1714-23.

Sugita J

Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor. Bone Marrow Transplant. 2023. DOI: 10.1038/s41409-023-02162-6

Imamura M

Role of loss and skew of X chromosome inactivation for developing myelodysplastic syndrome in patients with Klinefelter syndrome: A brief review of the literature. Leukemia Research Reports doi: 10.1016/j.lrr.2023.100396.

Imamura M

Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease. Cytotherapy 25(12):1251-1258,2023

Miki K

A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation. International Journal of Hematology 118(6):766-771,2023

Matsushima S

Clinical Outcomes after One-day or Two-day Intervals in Conditioning Regimens for allo-HCT. J Pediatr Hematol Oncol 45(3):e378-e383,2023

Yanagi M

Development of nephrotic syndrome during immunosuppressive treatment for aplastic anaemia with monosomy 7 in a 16-year-old boy: A case report. J Paediatr Child Health 59(2):365-367,2023

Sano H

Intralobar Nephroblastomatosis Mimicking Wilms Tumor Treated with Chemotherapy after Removal of the Affected Kidney. Clinical Pediatric Hematology-Oncology 30(1):21-24,2023

Miura M

Temporary reduction of immunosuppression enhances production of anti-S antibody against severe acute respiratory syndrome coronavirus 2 after vaccination in kidney transplant recipients. International Journal of Urology 29(12):1505-1510,2022

Miura M

Initial experience of transurethral ultrasound ablation of the prostate in Asia. BJUI Compass.3(6):405-407,2022

Sano H

Analysis of long-term renal function in patients with malignant solid tumors: Retrospective analysis using the estimated glomerular filtration rate. Pediatrics International.64(1):e15373. doi: 10.1111/ped.15373.